BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 24218590)

  • 1. BMP9 ameliorates amyloidosis and the cholinergic defect in a mouse model of Alzheimer's disease.
    Burke RM; Norman TA; Haydar TF; Slack BE; Leeman SE; Blusztajn JK; Mellott TJ
    Proc Natl Acad Sci U S A; 2013 Nov; 110(48):19567-72. PubMed ID: 24218590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGF2 ameliorates amyloidosis, increases cholinergic marker expression and raises BMP9 and neurotrophin levels in the hippocampus of the APPswePS1dE9 Alzheimer's disease model mice.
    Mellott TJ; Pender SM; Burke RM; Langley EA; Blusztajn JK
    PLoS One; 2014; 9(4):e94287. PubMed ID: 24732467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BMP9 (bone morphogenetic protein 9) induces NGF as an autocrine/paracrine cholinergic trophic factor in developing basal forebrain neurons.
    Schnitzler AC; Mellott TJ; Lopez-Coviella I; Tallini YN; Kotlikoff MI; Follettie MT; Blusztajn JK
    J Neurosci; 2010 Jun; 30(24):8221-8. PubMed ID: 20554873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholinergic degeneration is associated with increased plaque deposition and cognitive impairment in APPswe/PS1dE9 mice.
    Laursen B; Mørk A; Plath N; Kristiansen U; Bastlund JF
    Behav Brain Res; 2013 Mar; 240():146-52. PubMed ID: 23178660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical genetic activation of the cholinergic basal forebrain hippocampal circuit rescues memory loss in Alzheimer's disease.
    Liu W; Li J; Yang M; Ke X; Dai Y; Lin H; Wang S; Chen L; Tao J
    Alzheimers Res Ther; 2022 Apr; 14(1):53. PubMed ID: 35418161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BMP9 protects septal neurons from axotomy-evoked loss of cholinergic phenotype.
    Lopez-Coviella I; Mellott TJ; Schnitzler AC; Blusztajn JK
    PLoS One; 2011; 6(6):e21166. PubMed ID: 21695154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential modulation of nerve growth factor receptor (p75) and cholinergic gene expression in purified p75-expressing and non-expressing basal forebrain neurons by BMP9.
    Schnitzler AC; Lopez-Coviella I; Blusztajn JK
    Brain Res; 2008 Dec; 1246():19-28. PubMed ID: 18952073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone morphogenetic protein 9 induces the transcriptome of basal forebrain cholinergic neurons.
    Lopez-Coviella I; Follettie MT; Mellott TJ; Kovacheva VP; Slack BE; Diesl V; Berse B; Thies RS; Blusztajn JK
    Proc Natl Acad Sci U S A; 2005 May; 102(19):6984-9. PubMed ID: 15870197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired hippocampal acetylcholine release parallels spatial memory deficits in Tg2576 mice subjected to basal forebrain cholinergic degeneration.
    Laursen B; Mørk A; Plath N; Kristiansen U; Bastlund JF
    Brain Res; 2014 Jan; 1543():253-62. PubMed ID: 24231553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway.
    Jaffar S; Counts SE; Ma SY; Dadko E; Gordon MN; Morgan D; Mufson EJ
    Exp Neurol; 2001 Aug; 170(2):227-43. PubMed ID: 11476589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal BMP9 Ameliorates Alzheimer Disease-Like Pathology and Cognitive Deficits in APP/PS1 Transgenic Mice.
    Wang Z; Xiong L; Wan W; Duan L; Bai X; Zu H
    Front Mol Neurosci; 2017; 10():32. PubMed ID: 28228716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMP9 ameliorates amyloid pathology by promoting low-density lipoprotein receptor-related protein 1 expression in APP/PS1 transgenic mice.
    Xiong L; Wang Z
    Neurosci Lett; 2023 Mar; 801():137159. PubMed ID: 36858307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunolesion-induced loss of cholinergic projection neurones promotes β-amyloidosis and tau hyperphosphorylation in the hippocampus of triple-transgenic mice.
    Härtig W; Saul A; Kacza J; Grosche J; Goldhammer S; Michalski D; Wirths O
    Neuropathol Appl Neurobiol; 2014 Feb; 40(2):106-20. PubMed ID: 23566195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choline Supplementation Ameliorates Behavioral Deficits and Alzheimer's Disease-Like Pathology in Transgenic APP/PS1 Mice.
    Wang Y; Guan X; Chen X; Cai Y; Ma Y; Ma J; Zhang Q; Dai L; Fan X; Bai Y
    Mol Nutr Food Res; 2019 Sep; 63(18):e1801407. PubMed ID: 31298459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small molecule modulation of TrkB and TrkC neurotrophin receptors prevents cholinergic neuron atrophy in an Alzheimer's disease mouse model at an advanced pathological stage.
    Gonzalez S; McHugh TLM; Yang T; Syriani W; Massa SM; Longo FM; Simmons DA
    Neurobiol Dis; 2022 Jan; 162():105563. PubMed ID: 34838668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural stem cell transplantation improves learning and memory by protecting cholinergic neurons and restoring synaptic impairment in an amyloid precursor protein/presenilin 1 transgenic mouse model of Alzheimer's disease.
    Zhu Q; Zhang N; Hu N; Jiang R; Lu H; Xuan A; Long D; Chen Y
    Mol Med Rep; 2020 Mar; 21(3):1172-1180. PubMed ID: 31922229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perinatal Choline Supplementation Reduces Amyloidosis and Increases Choline Acetyltransferase Expression in the Hippocampus of the APPswePS1dE9 Alzheimer's Disease Model Mice.
    Mellott TJ; Huleatt OM; Shade BN; Pender SM; Liu YB; Slack BE; Blusztajn JK
    PLoS One; 2017; 12(1):e0170450. PubMed ID: 28103298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation of NSC-derived cholinergic neuron-like cells improves cognitive function in APP/PS1 transgenic mice.
    Gu G; Zhang W; Li M; Ni J; Wang P
    Neuroscience; 2015 Apr; 291():81-92. PubMed ID: 25681520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute Down-regulation of BDNF Signaling Does Not Replicate Exacerbated Amyloid-β Levels and Cognitive Impairment Induced by Cholinergic Basal Forebrain Lesion.
    Turnbull MT; Boskovic Z; Coulson EJ
    Front Mol Neurosci; 2018; 11():51. PubMed ID: 29520217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis.
    Boncristiano S; Calhoun ME; Kelly PH; Pfeifer M; Bondolfi L; Stalder M; Phinney AL; Abramowski D; Sturchler-Pierrat C; Enz A; Sommer B; Staufenbiel M; Jucker M
    J Neurosci; 2002 Apr; 22(8):3234-43. PubMed ID: 11943824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.